Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glycocalyx | 15 | 2024 | 97 | 5.100 |
Why?
|
Heparitin Sulfate | 17 | 2024 | 223 | 4.320 |
Why?
|
Lung Injury | 11 | 2024 | 422 | 3.710 |
Why?
|
Glycosaminoglycans | 8 | 2023 | 607 | 2.880 |
Why?
|
Sepsis | 19 | 2024 | 2585 | 2.750 |
Why?
|
Endothelium | 5 | 2019 | 765 | 1.730 |
Why?
|
Acute Lung Injury | 9 | 2024 | 367 | 1.660 |
Why?
|
Lung | 26 | 2024 | 10002 | 1.610 |
Why?
|
Lymphoma, Mantle-Cell | 2 | 2023 | 237 | 1.420 |
Why?
|
Endothelium, Vascular | 8 | 2024 | 4431 | 1.030 |
Why?
|
Respiratory Insufficiency | 5 | 2023 | 1230 | 0.960 |
Why?
|
Endotoxemia | 2 | 2018 | 196 | 0.930 |
Why?
|
Pneumonia, Bacterial | 2 | 2023 | 317 | 0.850 |
Why?
|
Oligosaccharides | 4 | 2023 | 406 | 0.810 |
Why?
|
Fellowships and Scholarships | 4 | 2024 | 1117 | 0.800 |
Why?
|
Pneumonia | 5 | 2022 | 2143 | 0.790 |
Why?
|
Silver Staining | 1 | 2021 | 62 | 0.750 |
Why?
|
Fluid Therapy | 3 | 2019 | 579 | 0.740 |
Why?
|
Glucuronidase | 5 | 2020 | 202 | 0.740 |
Why?
|
Pulmonary Atelectasis | 1 | 2022 | 143 | 0.730 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2021 | 112 | 0.720 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 3 | 2023 | 698 | 0.690 |
Why?
|
Endothelial Cells | 8 | 2024 | 3549 | 0.670 |
Why?
|
Neutrophils | 5 | 2017 | 3767 | 0.660 |
Why?
|
Critical Illness | 4 | 2022 | 2723 | 0.650 |
Why?
|
Sulfotransferases | 1 | 2019 | 150 | 0.630 |
Why?
|
Heparin | 4 | 2020 | 1634 | 0.620 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2021 | 1741 | 0.620 |
Why?
|
Interleukin-18 | 1 | 2020 | 250 | 0.610 |
Why?
|
Blood Coagulation Disorders | 1 | 2020 | 350 | 0.550 |
Why?
|
Bleomycin | 3 | 2020 | 494 | 0.550 |
Why?
|
Shock | 1 | 2018 | 314 | 0.530 |
Why?
|
Cell Communication | 3 | 2017 | 1657 | 0.510 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2017 | 592 | 0.490 |
Why?
|
Animals | 45 | 2024 | 168475 | 0.460 |
Why?
|
Mice | 28 | 2024 | 81539 | 0.450 |
Why?
|
Capillary Permeability | 3 | 2018 | 773 | 0.450 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 865 | 0.410 |
Why?
|
Ephrin-A1 | 1 | 2012 | 9 | 0.400 |
Why?
|
Chondroitin Sulfates | 4 | 2023 | 174 | 0.400 |
Why?
|
Lipopolysaccharides | 5 | 2024 | 2206 | 0.400 |
Why?
|
Receptor, EphA2 | 1 | 2012 | 41 | 0.390 |
Why?
|
Gap Junctions | 1 | 2013 | 230 | 0.390 |
Why?
|
Memory Disorders | 1 | 2019 | 1199 | 0.390 |
Why?
|
Cell-Derived Microparticles | 1 | 2013 | 161 | 0.380 |
Why?
|
Ventilator-Induced Lung Injury | 2 | 2012 | 120 | 0.380 |
Why?
|
Influenza, Human | 1 | 2022 | 1521 | 0.380 |
Why?
|
Acute Kidney Injury | 4 | 2019 | 1924 | 0.350 |
Why?
|
Cell Adhesion Molecules | 1 | 2016 | 1601 | 0.340 |
Why?
|
Shock, Septic | 1 | 2016 | 768 | 0.340 |
Why?
|
Hippocampus | 2 | 2019 | 3766 | 0.330 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 2 | 1 | 2008 | 2 | 0.320 |
Why?
|
Pulmonary Alveoli | 4 | 2024 | 652 | 0.320 |
Why?
|
Virulence | 2 | 2023 | 1303 | 0.320 |
Why?
|
Hyperoxia | 1 | 2011 | 258 | 0.320 |
Why?
|
Wounds and Injuries | 2 | 2024 | 2492 | 0.310 |
Why?
|
Editorial Policies | 2 | 2024 | 458 | 0.300 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1120 | 0.300 |
Why?
|
Guanylate Cyclase | 1 | 2008 | 205 | 0.290 |
Why?
|
Antiviral Agents | 1 | 2020 | 3060 | 0.290 |
Why?
|
Hyperalgesia | 1 | 2012 | 532 | 0.290 |
Why?
|
Syndecan-1 | 4 | 2023 | 163 | 0.290 |
Why?
|
Histones | 1 | 2017 | 2580 | 0.280 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1971 | 0.280 |
Why?
|
Humans | 56 | 2024 | 761596 | 0.270 |
Why?
|
Endotoxins | 3 | 2020 | 520 | 0.270 |
Why?
|
Resuscitation | 3 | 2019 | 673 | 0.260 |
Why?
|
Mice, Inbred C57BL | 12 | 2024 | 22174 | 0.260 |
Why?
|
Colorado | 2 | 2016 | 165 | 0.250 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2057 | 0.250 |
Why?
|
Hypertension, Pulmonary | 1 | 2016 | 1578 | 0.240 |
Why?
|
Tissue Plasminogen Activator | 2 | 2021 | 1164 | 0.240 |
Why?
|
Inflammation | 6 | 2022 | 10774 | 0.240 |
Why?
|
Respiratory Function Tests | 3 | 2020 | 1682 | 0.240 |
Why?
|
Anticoagulants | 1 | 2020 | 4812 | 0.230 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2024 | 60 | 0.230 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11904 | 0.220 |
Why?
|
Hospital Mortality | 2 | 2017 | 5293 | 0.220 |
Why?
|
Angiopoietin-2 | 2 | 2024 | 173 | 0.210 |
Why?
|
Staphylococcal Infections | 2 | 2024 | 1407 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.200 |
Why?
|
Rodentia | 1 | 2024 | 262 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.200 |
Why?
|
Cytotoxins | 1 | 2022 | 153 | 0.200 |
Why?
|
Disease Models, Animal | 10 | 2024 | 18255 | 0.200 |
Why?
|
Orthomyxoviridae Infections | 1 | 2024 | 254 | 0.200 |
Why?
|
Signal Transduction | 5 | 2024 | 23447 | 0.190 |
Why?
|
Cell Adhesion | 3 | 2013 | 3088 | 0.190 |
Why?
|
Ion Exchange | 1 | 2021 | 16 | 0.190 |
Why?
|
Calcitonin | 1 | 2022 | 329 | 0.190 |
Why?
|
Desiccation | 1 | 2021 | 78 | 0.180 |
Why?
|
Mice, Knockout | 7 | 2024 | 14417 | 0.180 |
Why?
|
Plasma | 1 | 2024 | 586 | 0.180 |
Why?
|
Mass Spectrometry | 2 | 2019 | 2192 | 0.180 |
Why?
|
Solutions | 1 | 2021 | 412 | 0.170 |
Why?
|
Respiration, Artificial | 2 | 2022 | 2630 | 0.170 |
Why?
|
Male | 26 | 2024 | 360846 | 0.170 |
Why?
|
Pneumococcal Infections | 1 | 2004 | 501 | 0.170 |
Why?
|
Atherosclerosis | 1 | 2016 | 3407 | 0.170 |
Why?
|
Blood Specimen Collection | 1 | 2020 | 238 | 0.160 |
Why?
|
Pulmonary Medicine | 1 | 2021 | 221 | 0.160 |
Why?
|
Thrombomodulin | 1 | 2019 | 105 | 0.160 |
Why?
|
Syndecans | 1 | 2018 | 75 | 0.160 |
Why?
|
Apoptosis | 2 | 2014 | 9490 | 0.160 |
Why?
|
Research Report | 1 | 2022 | 367 | 0.160 |
Why?
|
Atrial Natriuretic Factor | 1 | 2019 | 350 | 0.150 |
Why?
|
Patient Positioning | 1 | 2021 | 326 | 0.150 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2019 | 602 | 0.150 |
Why?
|
Protein Precursors | 1 | 2022 | 1132 | 0.150 |
Why?
|
Bacterial Adhesion | 1 | 2019 | 306 | 0.150 |
Why?
|
Diagnosis, Differential | 2 | 2023 | 12973 | 0.150 |
Why?
|
Polysaccharide-Lyases | 1 | 2017 | 47 | 0.150 |
Why?
|
Glucuronides | 1 | 2017 | 20 | 0.140 |
Why?
|
Long-Term Potentiation | 1 | 2019 | 293 | 0.140 |
Why?
|
Iatrogenic Disease | 1 | 2020 | 540 | 0.140 |
Why?
|
Alkalies | 1 | 2017 | 44 | 0.140 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9610 | 0.140 |
Why?
|
von Willebrand Factor | 1 | 2021 | 673 | 0.140 |
Why?
|
Cecum | 1 | 2017 | 233 | 0.140 |
Why?
|
Toll-Like Receptor 9 | 1 | 2018 | 233 | 0.140 |
Why?
|
Ligation | 1 | 2017 | 448 | 0.130 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2017 | 167 | 0.130 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2017 | 257 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 558 | 0.130 |
Why?
|
Sheep | 1 | 2018 | 1440 | 0.130 |
Why?
|
Punctures | 1 | 2017 | 366 | 0.130 |
Why?
|
Staphylococcus aureus | 2 | 2024 | 1457 | 0.120 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2006 | 1469 | 0.120 |
Why?
|
Membrane Proteins | 2 | 2024 | 7859 | 0.120 |
Why?
|
Enzyme Activation | 2 | 2012 | 3597 | 0.120 |
Why?
|
Trauma Severity Indices | 1 | 2016 | 478 | 0.120 |
Why?
|
Transcription Factors | 1 | 2014 | 12130 | 0.120 |
Why?
|
Epithelial Cells | 2 | 2017 | 3677 | 0.110 |
Why?
|
Aged | 9 | 2023 | 169310 | 0.110 |
Why?
|
Stroke | 1 | 2016 | 9758 | 0.110 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2019 | 1133 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 918 | 0.110 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15266 | 0.110 |
Why?
|
Periodicals as Topic | 1 | 2024 | 1463 | 0.110 |
Why?
|
Thoracostomy | 1 | 2013 | 74 | 0.100 |
Why?
|
Nicotine | 1 | 2017 | 680 | 0.100 |
Why?
|
Bacteria | 1 | 2023 | 2199 | 0.100 |
Why?
|
Caspase 3 | 1 | 2014 | 731 | 0.100 |
Why?
|
Chemokine CXCL1 | 1 | 2012 | 101 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2013 | 4352 | 0.100 |
Why?
|
Sex Factors | 2 | 2024 | 10554 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 256 | 0.090 |
Why?
|
Tobacco Smoke Pollution | 1 | 2017 | 819 | 0.090 |
Why?
|
MicroRNAs | 2 | 2017 | 3816 | 0.090 |
Why?
|
Prognosis | 3 | 2022 | 29629 | 0.090 |
Why?
|
Microcirculation | 1 | 2016 | 1272 | 0.090 |
Why?
|
Anemia | 1 | 2020 | 1509 | 0.090 |
Why?
|
Pandemics | 2 | 2021 | 8656 | 0.090 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2019 | 1723 | 0.090 |
Why?
|
Female | 16 | 2024 | 392705 | 0.090 |
Why?
|
Intestinal Perforation | 1 | 2012 | 249 | 0.090 |
Why?
|
Bacterial Proteins | 2 | 2024 | 3847 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 1 | 2014 | 2467 | 0.090 |
Why?
|
Matrix Metalloproteinases | 2 | 2024 | 393 | 0.090 |
Why?
|
Adoptive Transfer | 1 | 2012 | 819 | 0.080 |
Why?
|
Chemokine CCL2 | 1 | 2012 | 605 | 0.080 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 2008 | 100 | 0.080 |
Why?
|
Blood-Air Barrier | 1 | 2008 | 24 | 0.080 |
Why?
|
Gene Knockout Techniques | 1 | 2012 | 802 | 0.080 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2012 | 1126 | 0.080 |
Why?
|
Erythrocytes | 1 | 2018 | 2413 | 0.080 |
Why?
|
Surgical Flaps | 1 | 2017 | 1671 | 0.080 |
Why?
|
Burns | 1 | 2019 | 1882 | 0.080 |
Why?
|
Fibrosis | 1 | 2015 | 2049 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2008 | 214 | 0.070 |
Why?
|
Thrombosis | 1 | 2021 | 2942 | 0.070 |
Why?
|
Cyclic GMP | 1 | 2008 | 395 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2015 | 1726 | 0.070 |
Why?
|
Mice, Transgenic | 2 | 2022 | 9542 | 0.070 |
Why?
|
Graft Survival | 1 | 2017 | 3820 | 0.070 |
Why?
|
Adult | 8 | 2023 | 221210 | 0.070 |
Why?
|
Homeostasis | 1 | 2017 | 3323 | 0.070 |
Why?
|
Hypersensitivity | 1 | 2015 | 1171 | 0.060 |
Why?
|
Partial Pressure | 1 | 2006 | 245 | 0.060 |
Why?
|
Acute Disease | 1 | 2016 | 7237 | 0.060 |
Why?
|
Water | 1 | 2012 | 1411 | 0.060 |
Why?
|
Respiratory Muscles | 1 | 2006 | 142 | 0.060 |
Why?
|
Cyclic AMP | 1 | 2008 | 1463 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2024 | 151 | 0.060 |
Why?
|
Decorin | 1 | 2023 | 38 | 0.060 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2004 | 186 | 0.060 |
Why?
|
Aging | 1 | 2023 | 8710 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3429 | 0.060 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2017 | 426 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2872 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 1171 | 0.060 |
Why?
|
Cathelicidins | 1 | 2023 | 80 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2898 | 0.060 |
Why?
|
Research Design | 1 | 2019 | 6180 | 0.060 |
Why?
|
Leukocytes | 1 | 2012 | 2026 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20100 | 0.060 |
Why?
|
Trypsin | 1 | 2024 | 495 | 0.050 |
Why?
|
NF-kappa B | 1 | 2012 | 2490 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7391 | 0.050 |
Why?
|
Phosphofructokinase-2 | 1 | 2022 | 33 | 0.050 |
Why?
|
Disaccharides | 1 | 2023 | 170 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2016 | 3744 | 0.050 |
Why?
|
Time Factors | 2 | 2022 | 39969 | 0.050 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2004 | 422 | 0.050 |
Why?
|
Adolescent | 4 | 2024 | 88326 | 0.050 |
Why?
|
Blood Platelets | 1 | 2013 | 2479 | 0.050 |
Why?
|
Middle Aged | 8 | 2021 | 220921 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2017 | 2422 | 0.050 |
Why?
|
Stem Cells | 1 | 2015 | 3524 | 0.050 |
Why?
|
Young Adult | 3 | 2024 | 59260 | 0.050 |
Why?
|
Hydroxamic Acids | 1 | 2024 | 481 | 0.050 |
Why?
|
Child | 3 | 2024 | 80158 | 0.050 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2023 | 353 | 0.050 |
Why?
|
United States | 3 | 2024 | 72340 | 0.050 |
Why?
|
Carbon Dioxide | 1 | 2006 | 1147 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9319 | 0.050 |
Why?
|
Cell Movement | 1 | 2013 | 5205 | 0.050 |
Why?
|
Peptide Hydrolases | 1 | 2024 | 624 | 0.050 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 204 | 0.050 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2024 | 445 | 0.040 |
Why?
|
Prospective Studies | 3 | 2024 | 54423 | 0.040 |
Why?
|
Proteoglycans | 1 | 2023 | 803 | 0.040 |
Why?
|
Cricetulus | 1 | 2022 | 814 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2004 | 1835 | 0.040 |
Why?
|
Prone Position | 1 | 2021 | 196 | 0.040 |
Why?
|
Rehydration Solutions | 1 | 2019 | 43 | 0.040 |
Why?
|
Nitric Oxide | 1 | 2008 | 2136 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2023 | 829 | 0.040 |
Why?
|
Biofilms | 1 | 2024 | 627 | 0.040 |
Why?
|
Thorax | 1 | 2022 | 555 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2011 | 3066 | 0.040 |
Why?
|
CHO Cells | 1 | 2022 | 1387 | 0.040 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 619 | 0.040 |
Why?
|
Creatinine | 2 | 2015 | 1899 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2016 | 22176 | 0.040 |
Why?
|
Cricetinae | 1 | 2022 | 2423 | 0.040 |
Why?
|
Financing, Organized | 1 | 2019 | 204 | 0.040 |
Why?
|
Osteoclasts | 1 | 2022 | 711 | 0.040 |
Why?
|
RNA Transport | 1 | 2017 | 45 | 0.040 |
Why?
|
Kidney Tubules | 1 | 2019 | 449 | 0.040 |
Why?
|
Lectins | 1 | 2019 | 491 | 0.040 |
Why?
|
Carbohydrate Conformation | 1 | 2017 | 206 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2012 | 12794 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 9177 | 0.030 |
Why?
|
Osteoblasts | 1 | 2022 | 1143 | 0.030 |
Why?
|
Indoles | 1 | 2024 | 1833 | 0.030 |
Why?
|
Disease Progression | 1 | 2013 | 13510 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 2020 | 699 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2019 | 1157 | 0.030 |
Why?
|
Fibrinogen | 1 | 2019 | 888 | 0.030 |
Why?
|
Fibronectins | 1 | 2019 | 723 | 0.030 |
Why?
|
Pulmonary Fibrosis | 1 | 2019 | 505 | 0.030 |
Why?
|
Bronchi | 1 | 2019 | 845 | 0.030 |
Why?
|
Lung Diseases | 1 | 2024 | 1909 | 0.030 |
Why?
|
Protein Conformation | 1 | 2022 | 3968 | 0.030 |
Why?
|
Blood Urea Nitrogen | 1 | 2013 | 186 | 0.030 |
Why?
|
Catheterization | 1 | 2019 | 1428 | 0.030 |
Why?
|
Ovalbumin | 1 | 2015 | 677 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2639 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 1612 | 0.030 |
Why?
|
Lipocalins | 1 | 2013 | 161 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2020 | 1651 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2395 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2014 | 436 | 0.030 |
Why?
|
Acute-Phase Proteins | 1 | 2013 | 250 | 0.030 |
Why?
|
Societies, Medical | 1 | 2024 | 3905 | 0.030 |
Why?
|
Protein Kinases | 1 | 2019 | 1608 | 0.020 |
Why?
|
Teaching | 1 | 2019 | 1170 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2021 | 2084 | 0.020 |
Why?
|
Models, Molecular | 1 | 2022 | 5439 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 983 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4125 | 0.020 |
Why?
|
Immunization | 1 | 2015 | 1227 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2021 | 2759 | 0.020 |
Why?
|
Peroxidase | 1 | 2013 | 609 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 8002 | 0.020 |
Why?
|
Swine | 1 | 2019 | 5915 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2013 | 719 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 80647 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1188 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2013 | 1175 | 0.020 |
Why?
|
Gene Deletion | 1 | 2015 | 2665 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 6214 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8181 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15601 | 0.020 |
Why?
|
Nanoparticles | 1 | 2017 | 1958 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7406 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2178 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2017 | 1922 | 0.010 |
Why?
|
Odds Ratio | 1 | 2017 | 9647 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2015 | 3713 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15843 | 0.010 |
Why?
|
Crohn Disease | 1 | 2017 | 2279 | 0.010 |
Why?
|
Risk Factors | 2 | 2022 | 74213 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2013 | 3208 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58984 | 0.010 |
Why?
|
Cohort Studies | 1 | 2006 | 41495 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36193 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42232 | 0.010 |
Why?
|
Cognition | 1 | 2019 | 6992 | 0.010 |
Why?
|
Rats | 1 | 2017 | 23741 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 3204 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26129 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39106 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 18966 | 0.010 |
Why?
|
Hospitalization | 1 | 2017 | 10721 | 0.010 |
Why?
|
Algorithms | 1 | 2017 | 14033 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 64685 | 0.010 |
Why?
|